Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
University of Alabama/Children's of Alabama, Birmingham, Alabama Arkansas Children's Hospital, Little Rock, Arkansas Connecticut Children's Hospital, Hartford, Connecticut Nicklaus Children's Hospital, Miami, Florida Arnold Palmer Hospital for Children, Orlando, Florida St. Joseph's Children's Hospital, Tampa, Florida Kapiolani Medical Center for Women and Children, Honolulu, Hawaii Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey, Pennsylvania Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee Children's Medical Center, Dallas, Texas